Key words: Probiotics, Oral microbiota, Geriatric dentistry

Introduction

The global demographic shift toward an aging population has underscored the urgency of addressing oral health in the elderly. People frequently face a growing number of dental issues as they become older, from xerostomia and weakened immune systems to heightened vulnerability to oral cavities and periodontal disease. Comorbidities and polypharmacy often exacerbate these oral health issues, making typical preventive and therapeutic strategies in elderly dentistry more difficult. The FAO/WHO defines probiotics as “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host.”¹ In this context, probiotics have become a viable supplementary technique to inhibit infections, regulate oral microbial ecosystems, and strengthen mucosal defences.

This narrative review highlights the promise of probiotics in geriatric dental care by synthesizing mechanisms of action, clinical study evidence, advantages, limits, and future prospects, particularly in older adults.

Mechanisms of Action

Like the intestinal tract, the oral cavity is home to a dynamic and extremely complex microbial ecology made up of hundreds of different types of bacteria, fungi, and viruses that coexist in a delicate equilibrium. Maintaining dental homeostasis and avoiding disease depend heavily on this equilibrium. However, dysbiosis, a condition in which this equilibrium is upset, can lead to a number of oral health issues. Dysbiosis may worsen disorders including dental caries, periodontitis, halitosis, and oral candidiasis, especially in vulnerable populations like the elderly. These disruptions are particularly common in the elderly because of things like decreased salivary flow, pharmaceutical use, and compromised immune systems.

Competitive exclusion is one of the methods by which probiotics support dental health. During this process, pathogenic bacteria and helpful microbes battle for vital resources and adhesion sites on teeth, gingival tissues, and mucosal surfaces. For example, the ability of Lactobacillus reuteri and Streptococcus salivarius to colonize oral surfaces reduces the ability of pathogenic species like Porphyromonas gingivalis and Streptococcus mutans to adhere and multiply. They help maintain a healthy oral microbiota by doing this^2,3. Additionally, this colonization helps keep pathogenic species from recolonizing following mechanical or chemical cleaning and supports the long-term stability of beneficial microbial communities.

The synthesis of antibacterial compounds is another important process. Lactic acid, hydrogen peroxide, and bacteriocins are among the substances that probiotic species can emit; these substances have potent inhibitory effects on harmful microbes. By lowering pH and establishing conditions that are not conducive to the growth of pathogenic microbes, these metabolites change the local environment. Bacteriocins are proteinaceous toxins that specifically target and inhibit competing bacterial species by interfering with their vital metabolic activities or rupturing their membranes.⁴ By suppressing pathogenic populations and encouraging the survival of beneficial commensals, probiotics’ selective antibacterial action improves microbial harmony in the oral cavity.

Probiotics have significant immune-modulating properties in addition to their direct antibacterial actions. By increasing the synthesis of cytokines, antimicrobial peptides, and salivary immunoglobulin A (IgA), which are essential for the body’s first line of defense against infections, they can boost the host’s immune system. This immunostimulatory impact reduces the intensity of inflammatory reactions, boosts resistance to infections, and enhances mucosal immunity. A major contributing component to the pathogenesis of periodontal disorders is chronic inflammation, which causes bone resorption and tissue damage. Probiotics can decrease tissue damage and accelerate healing by encouraging the production of healthy cytokines and suppressing pro-inflammatory mediators including IL-1β, TNF-α, and IL-6.⁵

Additionally, some probiotic strains have antioxidant and anti-inflammatory qualities that help shield gingival tissues and stop damage brought on by oxidative stress. In inflammatory diseases like periodontitis, where excessive immune activity causes the collapse of supporting tooth structures, this is very helpful. Thus, consistent usage of probiotics may help to improve tissue healing, lower inflammation, restore microbial balance, and advance general oral health. In conclusion, probiotics are a viable and natural therapeutic method for preserving oral health and avoiding oral illnesses through processes like immune modulation, antimicrobial generation, and competitive exclusion.^2–5

Evidence from Clinical Studies in Elderly Populations

Probiotics have been shown to be effective in improving oral health in the elderly, a demographic that is especially susceptible to oral dysbiosis because of age-related immunosenescence, hyposalivation, medication usage, and denture wear. The aging process is often accompanied by physiological changes in saliva composition and flow rate, which alter the oral microenvironment and favor the proliferation of pathogenic species. These changes, combined with compromised immune responses and frequent use of broad-spectrum antibiotics or antiseptic mouth rinses, can lead to a reduction in beneficial bacteria and an overgrowth of opportunistic pathogens. Consequently, elderly individuals often experience higher rates of dental caries, periodontal diseases, halitosis, and oral candidiasis. Research indicates that probiotics could be valuable adjuncts for managing these age-associated oral health challenges by restoring microbial balance, reducing inflammation, and supporting mucosal immunity.

A randomized, double-blind, placebo controlled study by Hatakka et al. demonstrated that probiotic cheese supplemented with Lactobacillus rhamnosus GG significantly decreased Candida counts in the saliva and oral mucosa of elderly participants.⁶ This study provided one of the earliest pieces of evidence supporting the role of probiotics in controlling fungal colonization in the geriatric population. In addition to lowering Candida levels, the probiotic intervention was well tolerated and showed potential in improving oral comfort, suggesting that dairy-based probiotic products may serve as both nutritional and therapeutic tools for older adults. Furthermore, a follow-up study by the same research group revealed that daily consumption of probiotic cheese not only reduced oral yeast counts but also enhanced salivary flow and alleviated symptoms of xerostomia, or dry mouth, a common problem among the elderly.8 Improved salivary secretion contributes to better lubrication, antimicrobial defense, and remineralization of tooth enamel, all of which are essential for maintaining oral health and comfort in this vulnerable population.

Similarly, a clinical trial conducted by Shimauchi et al. evaluated the impact of Lactobacillus salivarius WB21 tablets on oral health parameters in older adults. Over an 8-week intervention period, participants who received the probiotic tablets showed significant improvements in periodontal markers, including reduced plaque accumulation, decreased gingival inflammation, and shallower probing depths compared to the placebo group.⁹ These findings indicate that certain probiotic strains can positively influence periodontal health by suppressing pathogenic bacteria such as Porphyromonas gingivalis and Treponema denticola, while simultaneously supporting beneficial microorganisms that maintain tissue integrity.

Another study conducted by Kraft-Bodi examined how lozenges containing Lactobacillus reuteri influenced the oral microbiota and yeast levels in frail elderly individuals residing in assisted living facilities. After 12 weeks of probiotic use, a significant reduction in oral Candida levels was observed, particularly in participants who initially had higher fungal loads.¹⁰ This suggests that L. reuteri may exert a protective role against fungal overgrowth, possibly through competition for adhesion sites and production of antifungal compounds such as reuterin and lactic acid. Moreover, the use of probiotic lozenges was found to be practical and well accepted by older individuals, highlighting their potential as a convenient delivery method for daily oral probiotic supplementation.

Supporting these clinical findings, a meta analysis by Lijun Hu et al. systematically reviewed several randomized controlled trials and concluded that probiotic supplementation significantly decreased the incidence and recurrence of oral candidiasis among older adults.¹¹ The analysis emphasized the importance of strain specificity, as certain Lactobacillus and Bifidobacterium strains demonstrated stronger antifungal effects than others. The authors also noted that probiotics could enhance mucosal immunity by increasing salivary IgA levels and promoting the growth of commensal species that inhibit fungal adherence.

Collectively, these studies highlight the growing evidence that probiotics play a meaningful role in maintaining microbial balance and reducing the risk of opportunistic infections in the elderly. However, despite encouraging results, most clinical trials to date have been of relatively short duration, involved small sample sizes, and varied widely in terms of probiotic strains, doses, and delivery methods. Therefore, while the existing data are promising, they must be interpreted with caution. Future research should focus on large-scale, long-term clinical trials that specifically target elderly populations and standardize probiotic formulations. Such studies are essential for confirming efficacy, determining optimal dosages and administration routes, and ultimately establishing evidence-based clinical guidelines for probiotic use in geriatric oral healthcare.^6–11

Prosthodontic Considerations

Prosthodontic rehabilitation in elderly individuals often involves complete or partial dentures, implant-supported prostheses, and management of age-related oral conditions such as xerostomia, mucosal atrophy, and reduced neuromuscular coordination. These factors can significantly influence the oral microbiota and may predispose older adults to infections, particularly denture stomatitis and Candida-associated lesions. Incorporating probiotics as an adjunct in prosthodontic care offers promising benefits but requires careful consideration. Denture surfaces, especially acrylic bases, provide favorable environments for biofilm accumulation, making the choice of probiotic strain and delivery system crucial. Lozenges, probiotic-infused dairy products, and slow-release tablets may be more effective for denture wearers than topical formulations that rely on natural saliva flow¹². Additionally, the interaction between probiotics and denture hygiene practices must be assessed to avoid unintended reduction of probiotic viability through disinfectants or cleansers. Studies indicate that daily intake of Lactobacillus rhamnosus SP1 can improve denture-related Candida infections in institutionalized elders.¹³ For implant patients, probiotics may support peri implant mucosal health by reducing pathogenic bacterial loads, though evidence remains limited. Clinicians must also consider individual risks, particularly for medically compromised or immunosuppressed patients, where probiotic use should be closely monitored. Ultimately, a tailored approach—integrating strain specificity, patient prosthetic design, and overall oral condition—can optimize the therapeutic benefits of probiotics in prosthodontic care for elderly populations.

Probiotics- Considerations and Cautions

The safety and effectiveness of probiotics vary greatly depending on the strain being utilized; not all species offer advantages for dental health. The safety and effectiveness of probiotics vary greatly depending on the strain being utilized; not all species offer advantages for dental health. First, site-specific origin and mechanism of action should be used to guide the selection of probiotic strains.¹⁴ Healthy oral microbiota is the optimal source of oral probiotics, which can exhibit properties like immunological modulation, bacteriocin synthesis, biofilm interference, and competitive exclusion of pathogens. For instance, some strains of Lactobacillus paracasei and Lactobacillus rhamnosus co-aggregate with Streptococcus mutans and can successfully lower its levels in saliva, which is essential for preventing dental cavities.¹⁵ Other Lactobacilli strains showed no discernible effectiveness, however a two-strain combination of L. reuteri (ATCC 17930 and PTA 5289) markedly reduced the symptoms of chronic periodontitis.¹⁶

Notably, hyposalivation and the use of dentures frequently cause oral candidiasis in the elderly. Probiotic cheese decreased high oral Candida levels in older persons by 32%, lowering the risk of hyposalivation by 56%, according to a randomized controlled trial.⁷ Daily lozenges containing L. reuteri (DSM 17938 and ATCC PTA 5289) decreased the incidence of high Candida loads in frail nursing home residents (P < 0.05), but they had no discernible impact on gingival bleeding or plaque.¹⁰

Despite these advantages, there is still a lack of safety and effectiveness information about the use of probiotics in old, fragile, or medically impaired people. Probiotic translocation or opportunistic pathogenicity can cause major consequences including sepsis, endocarditis, or pneumonia in vulnerable groups, especially the elderly.¹⁸ Examples include Lactobacillus-related bacteremia in patients with gastrointestinal vulnerabilities and Saccharomyces boulardii associated fungemia in critically ill patients.^19,20 There is little regulatory control over probiotics because they are regarded as foods rather than medications; this raises questions about the strain integrity, purity, and manufacturing quality.

Safety information related to specific strains is crucial. Although Bacillus coagulans exhibits excellent toxicological outcomes, including no mutagenicity or teratogenicity even at large dosages, patients with impaired immune systems should still exercise caution. On the other hand, strains like L. bulgaricus GLB44 may not colonize the oral cavity, while having GRAS status and safety data, even for older adults. Whole genome sequencing, virulence and antibiotic resistance profiling, and clinical efficacy trials in older populations are essential components of a thorough strain level assessment. Broad clinical recommendations are still premature in the absence of such data.

Conclusion

As the global population continues to age maintaining oral health has become an essential component in welfare of elderly. Probiotics present a promising adjunctive strategy for managing age-related oral challenges by restoring microbial balance, enhancing immune responses, and reducing pathogenic organisms associated with caries, periodontal disease, halitosis, and oral candidiasis. Clinical studies, though varied in methodology, consistently indicate beneficial effects, particularly in the reduction of Candida colonization and improvements in periodontal parameters. However, probiotic therapy is not without limitations. Strain specificity, delivery method, safety concerns in medically compromised individuals, and lack of regulatory oversight underscore the need for caution. More robust, long-term clinical trials focusing on elderly populations are essential to establish standardized dosing, efficacy, and safety. Prosthodontic considerations should be incorporated into probiotic treatment planning for elderly patients. Factors such as denture hygiene practices and the tendency for biofilm accumulation can influence the effectiveness of probiotic therapy. Additionally, selecting suitable probiotic delivery forms for denture wearers helps ensure optimal therapeutic outcomes.

References